Purchase Order 75N91019P00393
Award Date
5/29/19
Potential Completion Date
9/13/24
Potential Value
$12K
Federal Agency
National Cancer Institute
Awardee
N-Of-One, Inc.
Ultimate Awardee
Not listed
PSC Category
R499 - Support- Professional: Other
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Not Competed under SAP
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Bethesda, MD 20892, USA
Solicitation Procedures
Simplified Acquisition
Number Of Offers Received
1
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
The National Cancer Institute, a civilian agency within the U.S. Department of Health and Human Services, awarded a $14,225 firm fixed-price purchase order contract to N-Of-One, Inc., a self-certified small disadvantaged business, for laboratory testing services. This is the fifth prime federal contract awarded to N-Of-One by the National Cancer Institute between 2019 and 2020, with a total potential value across the awards of $89,700. The contract has an ultimate completion date of September...
The National Cancer Institute, a component of the National Institutes of Health within the Department of Health and Human Services, awarded a $25,000 purchase order to Nanostring Technologies, Inc. for testing services. The firm fixed price contract will be performed in Seattle, Washington over a four month period concluding in October 2023. The award provides testing services in support of the National Cancer Institute's biomedical research mission. No subcontractors or set aside designations...
The Department of Health and Human Services National Institutes of Health National Cancer Institute (HHS-NIH-NCI) awarded a $16,265 purchase order to Capralogics Inc. for testing services. The firm fixed price contract will be performed in Hardwick, Massachusetts over a three-month period from July 1, 2023 through September 30, 2023. As the intramural research program of the NCI, a component of the NIH focused on cancer research, this contract supports the agency's mission to lead the nation's...
<p>The Department of Health and Human Services National Institutes of Health National Cancer Institute awarded a firm fixed-price purchase order to C S Bio Co., a Minority Owned Business, Subchapter S Corporation, for $18,175.00 in laboratory testing services. The contract has an anticipated completion date of August 31, 2024 and was awarded on April 1, 2024. The services will be performed in Bethesda, Maryland. No set-aside was used for this award.</p>
The Department of Health and Human Services National Institutes of Health National Cancer Institute (HHS-NIH-NCI) awarded a $24,500 purchase order to Somalogic Operating Co., Inc. doing business as CM Life Sciences II Inc. for laboratory testing services. The firm fixed price contract runs from September 1, 2023 through February 29, 2024 and will be performed in Boulder, Colorado. No additional details were provided regarding the scope of laboratory testing services requested under the...
The National Cancer Institute (NCI), part of the National Institutes of Health (NIH) under the Department of Health and Human Services (HHS), awarded a $50,105 firm-fixed-price purchase order to Oxford Nanopore Technologies Inc. for the procurement of a GridION instrument and license to support DNA and RNA sequencing research within the Division of Cancer Epidemiology and Genetics (DCEG), Laboratory of Translational Genomics. The contract has an ultimate completion date of November 29, 2024...
<p>The Department of Health and Human Services National Institutes of Health National Cancer Institute awarded a $17,640 purchase order to Human Metabolome Technologies America, Inc. for testing services. The firm fixed price contract will be performed in Boston, Massachusetts over a three month period concluding in October 2023. The award provides testing services in support of the National Cancer Institute's research efforts. No subcontractors or set aside designations were identified.</p>
The Department of Health and Human Services National Institutes of Health National Cancer Institute awarded a $23,520 purchase order to Human Metabolome Technologies America, Inc. for laboratory testing services. The firm fixed price contract has a period of performance from August 22, 2023 through November 21, 2023 for work to be conducted in Boston, Massachusetts. No subcontractors or set aside designations were identified. The award provides laboratory testing support for the National...
The National Cancer Institute (NCI), part of the Department of Health and Human Services, awarded a $244,943 firm fixed-price purchase order contract to the Public Health Institute, a non-profit organization, to conduct the NCI Patterns of Care Study for prostate cancer, ovarian cancer, and small intestines cancer diagnosed in 2021. The contract, which has no set-aside designation, will involve abstracting medical records to describe cancer treatment patterns, compare treatments over time and...
<p>The National Cancer Institute (NCI) awarded a $199,996.00 Firm Fixed Price contract to Operational Technologies Corporation, a minority-owned, small disadvantaged, veteran-owned business, for Research & Development in Biomedical Basic Research. The contract has a completion date of June 22, 2014 and was set aside for small businesses. As a civilian agency, the NCI focuses on cancer research and this contract contributes to their broader medical research initiatives.</p>